Recent Laboratory Diagnostic & Testing Substances M&A deals

These are recent M&A deals we’ve tracked in Laboratory Diagnostic & Testing Substances. You can click into any transaction for full details, then build valuation comps or pipeline views directly in the Dealert platform.

In total, Dealert has recorded 7 deals in this market segment.

For continuous monitoring and email alerts on new transactions, use our M&A deal tracker or sign up to search the full database with deeper filters.

M&A deal tracker Sign up to search M&A deals database

Latest verified deals in Laboratory Diagnostic & Testing Substances 7 deals in total

Access full database

Showing up to 10 of the most recent transactions in this slice. Inside Dealert you can apply additional filters (size, buyer type, multiples) and export the full set into Excel.

	Target	Buyer / Investor	Industry	Deal type	Country	Year
View deal	Kova International, Inc.	LGC Group	Healthcare Equipment & Supplies	Buyout	United States of America	2023
View deal	Nordic Biomarker	Procuritas Capital Investors	Healthcare Equipment & Supplies	Growth Equity & Expansion Capital	Sweden	2022
View deal	Apijã, Laborsys, Macromed	Viveo	Healthcare Equipment & Supplies	Buy & Build / Roll-Up	Brazil	2021
View deal	Mabiotech	Best Health	Healthcare Equipment & Supplies	Buy & Build / Roll-Up	Morocco	2020
View deal	Tulip Diagnostics	PerkinElmer	Other	Merger	India	2017
View deal	BBI Diagnostics Group	Exponent Private Equity	Healthcare Providers & Services	Buyout	United Kingdom	2015
View deal	Cliniqa	Bio-Techne	Other	Merger	United States of America	2015

This is only a subset of the available deals. For full history, more filters, and exports, use the main search inside Dealert.

Turn this view into an always-on alert

Use our M&A deal tracker to save this segment as a tracker. Set your criteria once, and get new matching deals by email daily, weekly, or monthly.

Set up a tracker for Laboratory Diagnostic & Testing Substances